HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: An association of HIV-1 subtypes with exposure categories

Journal of Clinical Virology

Volumn 51, Issue 3, 2011, Pages 186-191

  Gräf, Tiago ^a   Passaes, Caroline P B ^b   Ferreira, Luis G E ^a   Grisard, Edmundo C ^a   Morgado, Mariza G ^b   Bello, Gonzalo ^b   Pinto, Aguinaldo R ^c  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Hospital Regional Homero de Miranda Gomes   (Brazil)

Author keywords

Drug resistance mutations; HIV 1; Molecular epidemiology; Southern Brazil

Indexed keywords

INTEGRASE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; DATA BASE; DRUG DEPENDENCE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MOSAIC VIRUS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS GENE; VIRUS LOAD; VIRUS MUTATION; VIRUS RECOMBINANT;

ADULT; ANTI-HIV AGENTS; BRAZIL; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PREVALENCE; VIRAL PROTEINS;

EID: 79959253276     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.04.011     Document Type: Article

References (39)

1. Boletim epidemiológico, AIDS & DST 2010, Ministério da Saúde, Brasil.
2. Couto-Fernandez J.C., Morgado M.G., Bongertz V., Tanuri A., Andrade T., Brites C., et al. HIV-1 subtyping in Salvador, Bahia, Brazil: a city with African sociodemographic characteristics. J Acquir Immune Defic Syndr 1999, 22(3):288-293.
3. Bongertz V., Bou-Habib D.C., Brigido L.F., Caseiro M., Chequer P.J., Couto-Fernandez J.C., et al. HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV isolation and characterization. J Acquir Immune Defic Syndr 2000, 23(2):184-193.
4. Brindeiro R.M., Diaz R.S., Sabino E.C., Morgado M.G., Pires I.L., Brigido L., et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS 2003, 17(7):1063-1069.
5. Gadelha S.R., Shindo N., Cruz J.N., Morgado M.G., Galvao-Castro B. Molecular epidemiology of human immunodeficiency virus-1 in the state of Ceara, Northeast, Brazil. Mem Inst Oswaldo Cruz 2003, 98(4):461-463.
6. Cabral V.P., Cunha C.B., Magalhaes E.F., Pinto-Neto L.F., Couto-Fernandez J.C., Dietze R., et al. Human immunodeficiency virus type-1 subtypes of infected patients in Espirito Santo, Brazil. Mem Inst Oswaldo Cruz 2006, 101(8):881-885.
7. Veras N.M., Veras V.S., Ramalho E.D., Kyaw C., Silva R.R., Brigido M.M., et al. HIV type 1 genetic variability in central Brazil. AIDS Res Hum Retroviruses 2007, 23(12):1481-1490.
8. Cardoso L.P., Queiroz B.B., Stefani M.M. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil. J Clin Virol 2009, 46(2):134-139.
9. Machado L.F., Ishak M.O., Vallinoto A.C., Lemos J.A., Azevedo V.N., Moreira M.R., et al. Molecular epidemiology of HIV type 1 in northern Brazil: identification of subtypes C and D and the introduction of CRF02_AG in the Amazon region of Brazil. AIDS Res Hum Retroviruses 2009, 25(10):961-966.
10. Soares E.A., Santos R.P., Pellegrini J.A., Sprinz E., Tanuri A., Soares M.A. Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in southern Brazil. J Acquir Immune Defic Syndr 2003, 34(5):520-526.
11. Rodrigues R., Scherer L.C., Oliveira C.M., Franco H.M., Sperhacke R.D., Ferreira J.L., et al. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Virus Res 2006, 116(1-2):201-207.
12. Santos A.F., Schrago C.G., Martinez A.M., Mendoza-Sassi R., Silveira J., Sousa T.M., et al. Epidemiologic and evolutionary trends of HIV-1 CRF31_BC-related strains in southern Brazil. J Acquir Immune Defic Syndr 2007, 45(3):328-333.
13. Brigido L.F., Nunes C.C., Oliveira C.M., Knoll R.K., Ferreira J.L., Freitas C.A., et al. HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. AIDS Res Hum Retroviruses 2007, 23(12):1579-1586.
14. Locateli D., Stoco P.H., de Queiroz A.T., Alcantara L.C., Ferreira L.G., Zanetti C.R., et al. Molecular epidemiology of HIV-1 in Santa Catarina State confirms increases of subtype C in Southern Brazil. J Med Virol 2007, 79(10):1455-1463.
15. Ferreira J.L., Thomaz M., Rodrigues R., Harrad D., Oliveira C.M., Oliveira C.A., et al. Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: preponderance of clade C among males with recent infections. Mem Inst Oswaldo Cruz 2008, 103(8):800-808.
16. Rodrigues R., Manenti S., Romao P.R., de Paula Ferreira J.L., Batista J.P., Siqueira A.F., et al. Young pregnant women living with HIV/AIDS in Criciuma, Southern Brazil, are infected almost exclusively with HIV type 1 clade C. AIDS Res Hum Retroviruses 2010, 26(3):351-357.
17. Toledo P.V., de Carvalho D.S., de Rossi S.G., Brindeiro R., de Queiroz-Telles F. Genetic diversity of human immunodeficiency virus-1 isolates in Parana, Brazil. Braz J Infect Dis 2010, 14(3):230-236.
18. Inocencio L.A., Pereira A.A., Sucupira M.C., Fernandez J.C., Jorge C.P., Souza D.F., et al. Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV. J Int AIDS Soc 2009, 12(1):20.
19. Sprinz E., Netto E.M., Patelli M., Lima J.S., Furtado J.J., da Eira M., et al. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses 2009, 25(9):861-867.
20. Sucupira M.C., Caseiro M.M., Alves K., Tescarollo G., Janini L.M., Sabino E.C., et al. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS 2007, 21(2):116-128.
21. de Sa-Filho D.J., Ambar R.F., Duarte N.B., Matias R.B., Candido V., Gagliani L.H., et al. HIV type 1 diversity from newly diagnosed patients in Santos metropolitan area/Brazil. AIDS Res Hum Retroviruses 2009, 25(9):925-929.
22. Pedroso C., Queiroz A.T., Alcantara L.C., Drexler J.F., Diaz R.S., Weyll N., et al. High prevalence of primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a northeast state of Brazil. J Acquir Immune Defic Syndr 2007, 45(2):251-253.
23. Delwart E.L., Herring B., Rodrigo A.G., Mullins J.I. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. PCR Methods Appl 1995, 4(5):S202-S216.
24. Bello G., Passaes C.P., Guimaraes M.L., Lorete R.S., Matos Almeida S.E., Medeiros R.M., et al. Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 2008, 22(15):1993-2000.
25. Passaes C.P., Bello G., Lorete R.S., Matos Almeida S.E., Junqueira D.M., Veloso V.G., et al. Genetic characterization of HIV-1 BC recombinants and evolutionary history of the CRF31_BC in Southern Brazil. Infect Genet Evol 2009, 9(4):474-482.
26. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22(22):4673-4680.
27. Tamura K., Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 1993, 10(3):512-526.
28. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24(8):1596-1599.
29. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980, 16(2):111-120.
30. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999, 73(1):152-160.
31. Bennett D.E., Camacho R.J., Otelea D., Kuritzkes D.R., Fleury H., Kiuchi M., et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009, 4(3):e4724.
32. Shafer R.W., Rhee S.Y., Pillay D., Miller V., Sandstrom P., Schapiro J.M., et al. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 2007, 21(2):215-223.
33. Bello G., Aulicino P.C., Ruchansky D., Guimarães M.L., Lopez-Galindez C., Casado C., et al. Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay. Retrovirology 2010, 22(3):7-22.
34. Brigido L.F., Ferreira J.L., Almeida V.C., Rocha S.Q., Ragazzo T.G., Estevam D.L., et al. Type 1 C expansion into the State of São Paulo, Brazil. AIDS Res Hum Retroviruses 2010, 26(00):1-6.
35. Payne B.A., Nsutebu E.F., Hunter E.R., Olarinde O., Collini P., Dunbar J.A., et al. Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort. J Antimicrob Chemother 2008, 62(3):464-468.
36. Lataillade M., Chiarella J., Kozal M.J. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance. Antivir Ther 2007, 12(4):563-570.
37. Rhee S.Y., Liu T.F., Kiuchi M., Zioni R., Gifford R.J., Holmes S.P., et al. Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors. Retrovirology 2008, 5(8):74.
38. Ceccherini-Silberstein F., Malet I., Fabeni L., Dimonte S., Svicher V., D'Arrigo R., et al. Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors. J Antimicrob Chemother 2010, 65(11):2305-2318.
39. Ersching J., Pinto A.R. HIV-1 vaccine clinical trials: the Brazilian experience. Rev Med Virol 2009, 19(5):301-311.